PKD2 and cancer: To date, several inhibitors of PKD2 have been developed, for example the small molecule inhibitor CRT0066101 and the pyrazolopyrimidine pan-PKD inhibitor SD-208, which both show anti-tumor activity in xenograft mouse models of various cancers [152,153].